Are exhaled nitric oxide measurements using the portable NIOX MINO repeatable?

Respiratory Research

Volumn 11, Issue , 2010, Pages

  Selby, Anna ^a   Clayton, Bernie ^b   Grundy, Jane ^b   Pike, Katy ^a   Drew, Kirsty ^c   Raza, Abid ^b   Kurukulaaratchy, Ramesh ^a,b,c   Arshad, S Hasan ^a,b,c   Roberts, Graham ^a,b,c  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b ST MARY S HOSPITAL   (United Kingdom)

^c UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE;

ADOLESCENT; ADULT; ANALYZER; ARTICLE; ASTHMA; CHILD; COHORT ANALYSIS; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; NITRIC OXIDE ANALYZER; PRESCHOOL CHILD; REPRODUCIBILITY; SCHOOL CHILD; SENSOR; SPIROMETRY; BREATH ANALYSIS; CLINICAL TRIAL; EQUIPMENT DESIGN; EXHALATION; INSTRUMENTATION; LUNG FUNCTION TEST; METABOLISM; OBSERVER VARIATION; PATHOPHYSIOLOGY; PREDICTION AND FORECASTING; UNITED KINGDOM; VALIDATION STUDY;

ADOLESCENT; ASTHMA; BREATH TESTS; CHILD; CLINICAL TRIALS AS TOPIC; COHORT STUDIES; EQUIPMENT DESIGN; EXHALATION; FEMALE; GREAT BRITAIN; HUMANS; MALE; NITRIC OXIDE; OBSERVER VARIATION; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; RESPIRATORY FUNCTION TESTS;

EID: 77954630960     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-11-43     Document Type: Article

References (28)

1. GINA Global Strategy for Asthma Management and Prevention. 2004, GINA.
2. von Mutius E. The burden of childhood asthma. Arch Dis Child 2000, 82(Suppl II):ii2-ii5. 1765082, 10833469.
3. The International Study of Asthma and Allergies in Childhood (ISAAC) steering committee Worldwide variations in the prevalence of asthma symptoms: the International Study of Asthma and Allergies in Childhood (ISAAC). Eur Resp J 1998, 12:315-35. The International Study of Asthma and Allergies in Childhood (ISAAC) steering committee.
4. American Thoracic Society, European Respiratory Society ATS/ERS Recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide. Am J Resp Crit Care Med 2005, 171:912-30. 10.1164/rccm.200406-710ST, 15817806, American Thoracic Society, European Respiratory Society.
5. Jatakanon A, Lim S, Kharitonov SA, Chung KF, Barnes PJ. Correlation between exhaled nitric oxide, sputum eosinophils, and methacholine responsiveness in patients with mild asthma. Thorax 1998, 53:91-5. 10.1136/thx.53.2.91, 1758706, 9624291.
6. Payne D, Adcock I, Wilson N, Oates T, Scallan M, Bush A. Relationship between exhaled nitric oxide and mucosal eosinophilic inflammation in children with difficult asthma, after treatment with oral prednisolone. Am J Respir Crit Care Med 2001, 164:1376-81.
7. Roberts G, Hurley C, Bush A, Lack G. Longitudinal study of grass pollen exposure, seasonal allergic asthma symptoms, and exhaled nitric oxide in childhood seasonal allergic asthma. Thorax 2004, 59:752-6. 10.1136/thx.2003.008722, 1747120, 15333850.
8. Jones SL, Kittelson J, Cowan JO, Flannery EM, Hancox RJ, McLachlan CR, Taylor DR. The Predictive value of exhaled nitric oxide measurements in assessing changes in asthma control. Am J Respir Crit Care Med 2001, 164:738-43.
9. Jones SL, Herbison P, Cowan JO, Flannery EM, Hancox RJ, McLachlan CR, Taylor DR. Exhaled NO and assessment of anti-inflammatory effects of inhaled steroid: dose-response relationship. Eur Respir J 2002, 20:601-8. 10.1183/09031936.02.00285302, 12358335.
10. Montuschi P, Mondino C, Koch P, Ciabattoni G, Barnes PJ, Baviera G. Effects of montelukast treatment and withdrawal on fractional exhaled nitric oxide and lung function in children with asthma. Chest 2007, 132:1876-81. 10.1378/chest.07-1587, 18079221.
11. Zacharasiewicz A, Wilson N, Lex C, Erin EM, Li AM, Hansel T, Khan M, Bush A. Clinical use of noninvasive measurements of airway inflammation in steroid reduction in children. Am J Respir Crit Care Med 2005, 171:1077-1082. 10.1164/rccm.200409-1242OC, 15709050.
12. Szefler SJ, Mitchell H, Sorkness CA, Gergen PJ, O'Connor GT, Morgan WJ, Kattan M, Pongracic JA, Teach SJ, Bloomberg GR, Eggleston PA, Gruchalla RS, Kercsmar CM, Liu AH, Wildfire JJ, Curry MD, Busse WW. Management of asthma based on exhaled nitric oxide in addition to guideline-based treatment for inner-city adolescents and young adults: a randomised controlled trial. Am J Resp Crit Care Medicine 2008, 372:1065-1072.
13. Jongste JC, Carraro S, Hop WC, Baraldi E. CHARISM Study Group Daily Telemonitoring of Exhaled Nitric Oxide and Symptoms in the Treatment of Childhood Asthma. Am J Respir Crit Care Med 2009, 179:93-97. 10.1164/rccm.200807-1010OC, 18931330, CHARISM Study Group.
14. Asthma UK. Where do We Stand?. Asthma in the UK Today 2004,
15. Alving K, Janson C, Nordvall L. Performance of a new hand-held device for exhaled nitric oxide measurement in adults and children. Respir Res 2006, 7:67. 10.1186/1465-9921-7-67, 1462993, 16626491.
16. Khalili B, Boggs PB, L BS. Reliability of a new hand-held device for the measurement of exhaled nitric oxide. Allergy 2007, 62:1171-4. 10.1111/j.1398-9995.2007.01475.x, 17845587.
17. Menzies D, Nair A, Lipworth BJ. Portable exhaled nitric oxide measurement: comparison with the "gold standard" technique. Chest 2007, 131:410-4. 10.1378/chest.06-1335, 17296641.
18. McGill C, Malik G, Turner SW. Validation of a hand-held exhaled nitric oxide analyzer for use in children. Pediatr Pulmonol 2006, 41:1053-7. 10.1002/ppul.20491, 16871592.
19. US Food and Drug Administration. accessed 17th April 2010., http://www.accessdata.fda.gov/cdrh_docs/pdf7/K072816.pdf
20. Aerocrine AB. Measuring exhaled NO with NIOX MINO®. (accessed 17th April 2010)., http://www.aerocrine.com/en/niox-mino/Procedure/
21. Gill M, Graff GR, Adler AJ, Dweik RA. Validation study of fractional exhaled nitric oxide measurements using a handheld monitoring device. J Asthma 2006, 43:731-4. 10.1080/02770900601031045, 17169823.
22. Tamasi L, Bohacs A, Bikov A, Andorka C, Rigo J, Losonczy G, Horvath I. Exhaled Nitric Oxide in Pregnant Healthy and Asthmatic Women. Journal of Asthma 2009, 46:786-791.
23. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, Grinten CP, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J. Standardisation of spirometry. Eur Resp J 2005, 26:319-38.
24. Dreborg S. Skin tests for the diagnosis of IgE-mediated allergy. Allergy 1989, 144(supple 10):31-37.
25. Aerocrine Guide to Interpretation of eNO Values. accessed 17th April 2010, Aerocrine., http://www.aerocrine.com/Global/pdf/Interpretation_guide.pdf
26. Gill M, Walker S, Khan A, Green SM, Kim L, Gray S, Krauss B. Exhaled nitric oxide levels during acute asthma exacerbation. Acad Emerg Med 2005, 12:579-86. 10.1111/j.1553-2712.2005.tb00910.x, 15995087.
27. Taylor DR, Pijnenburg MW, Smith AD, de Jongste JC. Exhaled nitric oxide measurements: clinical application and interpretation. Thorax 2006, 61:817-827. 10.1136/thx.2005.056093, 2117092, 16936238.
28. Schneider A, Tilemann L, Schermer T, Gindner L, Laux G, Szecsenyi J, Meyer FJ. Diagnosing Asthma in General Practice with Portable Exhaled Nitric Oxide Measurement - Results of a Prospective Diagnostic Study: FENO ≤ 16 ppb better than FENO ≤ 12 ppb to rule out mild and moderate to severe asthma. Respiratory Research 2009, 10:64.